1. Introduction {#s0005}
===============

While smoking and drinking have traditionally been associated with the occurrence of oropharyngeal cancer (OPC), currently between 70 and 90% of OPCs are now caused by oncogenic human papillomavirus (HPV) infections in the United States (US) ([@bb0140]). Between 1988 and 2004, the prevalence of HPV-OPC has risen by 225%, with approximately 7% of the population having an active oropharyngeal HPV infection at any given time ([@bb0030]; [@bb0065]). In the US, HPV-OPC cases have already outnumbered cases of cervical cancer ([@bb0025]).

HPV-OPC is more aggressive than non-HPV-OPC, and tends to occur in younger, male patients, with the median age of HPV-OPC patients at 58 years ([@bb0030]; [@bb0060]). Treatment for OPC often includes radiation and chemotherapy, which may be painful, expensive, and debilitating ([@bb0135]). Reconstructive surgery and maxillofacial prosthetics are sometimes needed to help patients recover function, reduce disfigurement, and improve quality of life ([@bb0135]). Side effects and complications of treatments are common and are associated with physical and economic burdens ([@bb0135]). Patients with advanced disease experience greater costs and burdens of disease and treatment ([@bb0135]). For these reasons, primary prevention of HPV-OPC is an important public health priority.

Given that secondary prevention is complicated, primary prevention of HPV-OPC, completing the HPV vaccine series in a timely manner, is critical. Currently, there is no FDA approved test available to detect HPV infections in the oropharynx ([@bb0025]), making early detection difficult. Visually detecting tumors in the deeper structures of the orpharynx is complicated ([@bb0080]). HPV vaccination in adolescence is the most effective primary prevention strategy to reduce the prevalence of HPV-OPC as the HPV vaccine offers protection against HPV 16 which account for the majority of HPV-OPC ([@bb0030]). Since 2011, the Advisory Committee on Immunization Practices (ACIP) has recommended that adolescents of both sexes receive the HPV vaccine series at ages 11 or 12 ([@bb0020]). Yet as of 2016, only 49.5% of adolescent females and 37.5% of adolescent males were up-to-date on HPV vaccinations in the US ([@bb0130]), far below the HealthyPeople 2020 goal of 80% ([@bb0070]). Promoting and administering the HPV vaccine in non-traditional locations such as dental offices may increase HPV vaccine uptake and completion. Recognizing the increasing trends of HPV-OPC in the population, the American Dental Association has strongly advocated for dental professionals to be educated about the relationship between HPV and OPC, pass that knowledge onto their patients, and encourage HPV vaccination to improve the prevention and screening of HPV-OPC in the dental setting ([@bb0005]; [@bb0010]). Indeed, the National HPV Vaccination Roundtable has recently developed a guide for dental providers to engage in HPV prevention in efforts provide dental providers with the needed resources to address this healthcare priority ([@bb0095]), despite the fact that the FDA has not yet approved the HPV vaccine for the prevention of OPC.

As a large majority of OPC is first detected in the oral cavity ([@bb0040]), dental providers already play an important role in the early detection of OPC when they perform routine oral cancer screenings. Adolescent patients see their dental providers around the same frequency as they see their medical providers ([@bb0100]), which presents a promising and untapped opportunity for dental providers to educate about and administer the HPV vaccine. However, the body of research examining dental providers\' willingness to recommend and administer the HPV vaccine is scant.

Oral health professionals including dentists and dental hygienists, and dental students have reported a lack of knowledge or awareness of HPV, the HPV vaccine, and the link between HPV and OPC ([@bb0015]; [@bb0125]; [@bb0045]). Knowledge levels about HPV and HPV-OPC prevention have been positively associated with communication with patients about HPV and sexually transmitted infections (STIs) among dental hygienists ([@bb0055]), and has been studied among dentists as well ([@bb0125]). Comfort in communicating to patients about HPV may be associated with educational level and gender in the dentist and dental hygienist professions ([@bb0125]; [@bb0110]; [@bb0035]). However, increased knowledge about HPV topics could address communication deficits and self-efficacy ([@bb0045]). Daley et al. found that dentists and dental hygienists who received information about the HPV vaccine from professional journals, continuing education, and oral health colleagues demonstrated greater readiness to discuss HPV ([@bb0055]; [@bb0050]). In addition to HPV knowledge, dental professionals\' willingness to discuss HPV may depend on patient and practice factors. Patient factors include discomfort talking about HPV with younger patients, and perceived susceptibility or lack of susceptibility of patient to HPV ([@bb0125]; [@bb0045]). Practice factors that have served as barriers to discussing HPV in the dental setting include liability issues, the lack of professional guidelines, limited time, concerns about confidentiality, role conflict with dental professionals becoming engaged in STI prevention, and discomfort discussing sexual history/topics ([@bb0045]; [@bb0050]). Furthermore, environmental considerations regarding the inability to offer greater privacy to patients to have sensitive discussions about HPV, and the lack of clinical procedures to collect vaccination or sexual history was also perceived as barriers to discussing the HPV vaccine ([@bb0125]).

Including HPV vaccination and education within the scope and role of oral health professionals will require a large shift in the professional culture of dentistry from early detection and treatment to also include primary prevention of HPV-OPC. Oral health students represent the next generation of dental professionals. Assessing their perspectives on the role of dental professionals in engaging in HPV-OPC prevention through HPV vaccination education with patients and HPV vaccination delivery will help guide future interventions for HPV education and HPV-cancer prevention in U.S. dental practices. The purpose of this study is to examine the factors associated with willingness of dental and dental hygiene students to 1) be trained to administer the HPV vaccine, and 2) to administer the HPV vaccine after receiving training.

2. Methods {#s0010}
==========

After obtaining Institutional Review Board approval, dental and dental hygiene programs in the US were approached via a convenience sampling approach in 2016. Out of 20 programs, 15 programs located in 8 states (Arizona, California, Colorado, Idaho, Nevada, Tennessee, Texas, and Utah) participated in this cross-sectional, quantitative study. Participating dental programs emailed their third and fourth year dental students or senior dental hygiene students about the study, and included a link to a 153-item, self-administered online survey in REDCap. The survey was administered the senior oral health students as it was assumed that they would have completed oral pathology coursework at the later years of the oral health program. Programs were also asked to twice remind students to complete the study at designated intervals. Questionnaires were anonymously completed, and collated through the REDCap platform. The median amount of time for students to complete the entire survey was 85 min. After submitting the survey, regardless of completion of all items, participants were reimbursed with a \$15 gift card as token of appreciation for their time.

2.1. Outcome variables {#s0015}
----------------------

Willingness to train to administer the HPV vaccine was measured by a question asking participants, "How willing would you be to participate in a training to administer the HPV vaccines in your dental practice". Willingness to administer the HPV vaccine was measured by a question asking participants, "If trained, how willing would you be to administer the HPV vaccines in your dental office" Responses were measured on a 4-point Likert scale where 0 = not at all willing, and 3 = very willing. Response was then dichotomized to "Less willing" ("not at all willing" and "somewhat willing") and "more willing" ("willing" and "very willing").

2.2. Independent variables {#s0020}
--------------------------

We reviewed the extant literature surrounding HPV vaccination and dental professions, and together with our previous research associated with HPV vaccination in non-oral health professional populations, compiled a priori independent variables to examine in this analysis.

### 2.2.1. Sociodemographics {#s0025}

Sociodemographic variables we examined included gender, age, ethnicity, race, and state of program; educational characteristics included prior degree and type of oral health program; and current clinical exposure with patients was assessed by number of patients that students worked within a week.

### 2.2.2. Sources of HPV vaccine information {#s0030}

Questions pertaining to sources of HPV vaccination information were adapted from Daley et al.\'s study on dentists\' readiness for discussing HPV vaccination with patients ([@bb0050]). Participants were allowed to select as many sources of HPV vaccine information that they were exposed to from a list that included 1) dental curriculum, 2) family/friend, 3) internet, 4) magazines, newspapers, other printed materials, 4) non-oral health colleague (e.g., medical doctor, nurse practitioner), 5) oral health colleague, 6) patient(s), 7) professional journal/publication (e.g., oral health journal), 8) radio, 9) television or commercials, or 10) other sources (open ended). The frequencies of each of these dichotomous variables were calculated. The top 5 most frequently reported sources of HPV vaccination were then included for analyses in unadjusted and adjusted multivariable logistic regression analyses.

### 2.2.3. HPV and HPV vaccine knowledge {#s0035}

Overall HPV vaccine knowledge was assessed using a scale developed by Rutkoski et al. ([@bb0120]). In addition, specific items of HPV and HPV vaccine knowledge related to oropharyngeal cancer were isolated for analysis.

### 2.2.4. Attitudes to engaging with patients about HPV and HPV vaccine {#s0040}

To assess participants\' attitudes toward HPV and HPV vaccine education in the dental setting, we looked at barriers related to discussing HPV vaccine, current communication practices related to HPV vaccine, and participants\' perceived scope of practice related to educating about, recommending, and administering the HPV vaccine to patients. These items were adapted from Daley et al.\'s study ([@bb0050]) which were adapted and refined in a pilot stage of this research ([@bb0120]). Barriers and professional scope of practice questions were based on a 5-point Likert scale ranging from "strongly disagree" to "strongly agree"; responses were then dichotomized for analysis to "did not agree" and "agree". Current communication practices were assessed with the question, "Which statement best describes how you communicate with patients about the HPV vaccine?" Possible responses were measured on a 5-item response scale to measure stages of readiness ([@bb0050]) and included: "I do not discuss it with my patients and have no plans to start", "I do not discuss it with my patients but have thought about it", "I sometimes discuss it with my patients", "I often discuss it with my patients", and "I always discuss it with my patients".

2.3. Statistical analyses {#s0045}
-------------------------

Descriptive statistics and unadjusted and adjusted multivariable logistic regression models were used to describe the sample and to assess factors associated with oral health students\' willingness to train to administer the HPV vaccine and to administer the HPV vaccine once trained. The median HPV knowledge score and interquartile ranges for those who were more willing and less willing to train, as well as those who were more willing and less willing to administer the HPV vaccine was produced. Logistic regression models were stratified by individual school to account for the sampling design. The sampling design was to invite several schools to participate. All independent variables from the univariate analyses were reanalyzed with unadjusted logistic regressions adjusting for the school cluster design of the study. Since education would be most similar within these schools (and potentially attitudes), each school was considered a strata in the analysis for the unadjusted logistic regression models. Significant findings in the unadjusted logistic regressions were retained for the adjusted multivariable models for each respective outcome. Odds ratios (OR) and 95% confidence intervals (CI) were produced. All analyses were conducted in SAS Version 9.4. Findings were considered statistically significant at the *p* \< 0.05 level.

3. Results {#s0050}
==========

After removing incomplete, duplicate, ineligible entries, and participants who did not identify their type of oral health program, records from a total of *N* = 306 participants were included for the analyses (*n* = 155, 68.0% third year dental students; *n* = 78, 25.5% fourth year dental students, *n* = 73, 23.9% dental hygiene students). [Table 1](#t0005){ref-type="table"} reports the descriptive statistics of the sample. The majority of the survey respondents were female (*n* = 215, 70.3%), between the ages of 18--29 years of age (*n* = 245, 80.1%), and non-Hispanic/Latino (*n* = 278, 90.8%). The majority were White (*n* = 190, 62.1%), and held at least an associate\'s degree or bachelor\'s degree prior to commencing their oral health program (*n* = 254, 83%). The majority had between 0 and 10 h of clinical time with patients weekly (*n* = 259, 84.6%). Most students came from programs in Arizona, California, and Texas (Arizona: *n* = 64, 20.9%; California: *n* = 71, 23.2%; Texas: *n* = 49, 16.0%; [Table 1](#t0005){ref-type="table"}). The median overall HPV vaccine knowledge score was 69.6%, and the interquartile range was 60.9% to 78.3%.Table 1Characteristics of participants (*N* = 306).Table 1Variablen (%)SociodemographicsGender Female215 (70.3)Age 18--29 years old245 (80.1)Ethnicity Non-Hispanic/Latino278 (90.8)Race White190 (62.1)Type of oral health program Dental hygiene73 (23.9) Dental-3rd year155 (68.0) Dental-4th year78 (25.5)Prior degree earned Associate or bachelor\'s degree254 (83.0)Number of patient visits per week 0--10259 (84.6)State of program Arizona64 (20.9) California71 (23.2) Colorado33 (10.8) Idaho9 (2.9) Nevada27 (8.8) Tennessee15 (4.9) Texas49 (16.0) Utah38 (12.4)  Top sources of HPV informationDental curriculum216 (70.6)Internet104 (34.0)Non-oral health colleague (e.g., medical doctor, nurse practitioner)63 (20.6)Family/friend62 (20.3)Professional journal/publication (e.g., oral health journal)54 (17.6)  HPV vaccine knowledge (correct responses)Overall HPV vaccine knowledgeMedian = 69.6%, IQR = 60.9%--78.3% HPV can cause oropharyngeal cancer286 (93.5) HPV vaccines can protect men and women against HPV related oropharyngeal cancer236 (77.1)  Barriers to discussing HPV (those who agreed)I do not have enough information about the HPV vaccines191 (62.4)I am concerned with the safety of the HPV vaccines39 (12.7)Liability reasons102 (33.3)I do not believe it is my role as an oral health professional to recommend the HPV vaccines to my patients76 (24.8)There are no established professional policies/guidelines pertaining to recommendation of the HPV vaccines125 (40.8)There is not enough time to discuss this during appointments126 (41.2)I am not comfortable discussing sexual history/topics with patients158 (51.6)Politics play a role in discussing HPV and the HPV vaccines in the dental office113 (36.9)Social and cultural norms play a role in discussing HPV and the HPV vaccines in the dental office229 (74.8)A patient\'s religious ideology plays a role in discussing HPV and the HPV vaccines in the dental office201 (65.7)  Communication about HPVDo not discuss HPV in the clinic setting and/or have no plans to start57 (18.6)  Scope of practiceDiscussing the link between HPV and oropharyngeal cancer falls within the scope and role of a dental professional256 (83.7)Recommending HPV vaccination falls within the scope and role of a dental professional177 (57.8)Administering the HPV vaccines inside the dental office falls within the scope and role of a dental professional54 (17.6)

3.1. Unadjusted and adjusted multivariable logistic regressions {#s0055}
---------------------------------------------------------------

[Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"} report the results for the unadjusted and adjusted multivariable logistic regressions (*N* = 306). [Table 2](#t0010){ref-type="table"} reports the analyses for the first outcome measure, willingness to train to administer the HPV vaccine, while [Table 3](#t0015){ref-type="table"} reports the analyses for the second outcome measure, willingness to administer the HPV vaccine once trained.Table 2Factors Associated with US Oral Health Students\' Willingness to Train to Administer the HPV Vaccine in 2016-- Unadjusted and Adjusted Multivariable Logistic Regression Models (N = 306).[a](#tf0005){ref-type="table-fn"}, [b](#tf0010){ref-type="table-fn"}Table 2VariableUnadjustedAdjustedOdds ratio95% CIOdds ratio95% CISociodemographicsGender MaleReference Female0.74(0.43--1.28)Age 18--29 years oldReference 30 years and above0.89(0.50--1.61)Ethnicity Non-Hispanic/LatinoReference Hispanic/Latino1.36(0.59--3.15)Race WhiteReference Other Race0.86(0.49--1.50)Type of oral health program Dental-3rd yearReference Dental hygiene0.88(0.50--1.54) Dental-4th year1.04(0.60--1.81)Prior degree earned No prior degreeReference Associate or bachelor\'s degree1.19(0.43--3.27) Master\'s degree or doctorate degree2.14(0.47--0.54)Number of patient visits per week 0--10Reference 11--200.99(0.42--2.32) 21+3.07(0.93--0.18)State of program ArizonaReference California0.62(0.31--1.26) Colorado0.62(0.26--1.47) Idaho0.37(0.09--1.50) Nevada0.37(0.15--0.92) Tennessee1.82(0.46--7.14) Texas0.61(0.28--1.32) Utah0.51(0.22--1.16)  Top 5 sources of HPV vaccine information reportedDental curriculum YesReference No0.89(0.53--1.49)Internet YesReference No0.65(0.39--1.07)Non-oral health colleague (e.g., medical doctor, nurse practitioner) YesReference No0.63(0.35--1.14)Family/friend YesReference No1.01(0.57--1.78)Professional journal/publication (e.g., oral health journal) YesReference No0.68(0.34--1.34)  HPV vaccine knowledgeHPV vaccine knowledge Below medianReference Above median1.04(0.98--1.10)HPV can cause oropharyngeal cancer TrueReference False/Don\'t know/Missing0.76(0.29--1.98)HPV vaccines can protect men and women against HPV related oropharyngeal cancer TrueReference False/Don\'t know/Missing0.97(0.56--1.68)  Barriers to discussing HPVI do not have enough information about the HPV vaccines Did not agreeReference Agreed0.79(0.49--1.28)I am concerned with the safety of the HPV vaccines Did not agreeReference Agreed0.59(0.29--1.18)Liability reasons Did not agreeReference Agreed0.84(0.51--1.36)I do not believe it is my role as an oral health professional to recommend the HPV vaccines to my patients Did not agreeReferenceReference Agreed0.41(0.24--0.71)0.73(0.37--1.44)There are no established professional policies/guidelines pertaining to recommendation of the HPV vaccines Did not agreeReference Agreed0.95(0.60--1.53)There is not enough time to discuss this during appointments Did not agreeReferenceReference Agreed0.60(0.37--0.98)0.63(0.37--1.09)I am not comfortable discussing sexual history/topics with patients Did not agreeReferenceReference Agreed0.55(0.34--0.89)0.81(0.37--1.09)Politics play a role in discussing HPV and the HPV vaccines in the dental office Did not agreeReference Agreed1.14(0.71--1.85)Social and cultural norms play a role in discussing HPV and the HPV vaccines in the dental office Did not agreeReference Agreed0.89(0.52--1.54)A patient\'s religious ideology plays a role in discussing HPV and the HPV vaccines in the dental office Did not agreeReference Agreed1.29(0.80--2.10)  Communication about HPVDo not discuss HPV in the clinic setting and/or have no plans to start Have discussedReferenceReference Have not discussed/No plans to start0.44(0.24--0.8)0.72(0.36--1.45)  Scope of practiceDiscussing the link between HPV and oropharyngeal cancer falls within the scope and role of a dental professional Did not agreeReference Agreed1.17(0.63--2.19)Recommending HPV vaccination falls within the scope and role of a dental professionalDid not agreeReferenceReferenceAgreed2.93(1.81--4.75)1.95(1.14--3.35)Administering the HPV vaccines inside the dental office falls within the scope and role of a dental professionalDid not agreeReferenceReferenceAgreed4.87(2.19--10.83)3.79(1.63--8.81)[^1][^2]Table 3Factors Associated with US Oral Health Students\' Willingness to Administer the HPV Vaccine in 2016-- Unadjusted and Adjusted Multivariable Logistic Regression Models (*N* = 306).[a](#tf0015){ref-type="table-fn"}, [b](#tf0020){ref-type="table-fn"}Table 3VariableUnadjustedAdjustedOdds ratio(95% CI)Odds ratio(95% CI)SociodemographicsGender MaleReference Female1.22(0.70--2.13)**Age** 18--29 years oldReference 30 years and above1.32(0.71--2.43)**Ethnicity** Non-Hispanic/LatinoReference Hispanic/Latino1.16(0.50--2.69)**Race** WhiteReference Other race0.78(0.44--1.36)Type of oral health program Dental-3rd yearReference Dental-4th year1.44(0.82--2.55) Dental hygiene1.39(0.78--2.47)Prior degree earned No prior degreeReference Associate or bachelor\'s degree0.99(0.34--2.88) Master\'s degree or doctorate degree2.54(0.57--11.30)Number of patient visits per week 0--10ReferenceReference 11--201.21(0.52--2.84)1.09(0.44--2.71) 21+4.40(1.16--16.75)4.47(1.14--17.58)State of program ArizonaReference California0.79(0.39--1.61) Colorado0.62(0.26--1.47) Idaho0.37(0.09--1.50) Nevada0.49(0.20--1.23) Tennessee2.95(0.61--14.28) Texas0.56(0.26--1.21) Utah0.78(0.34--1.81)  Top 5 sources of HPV vaccine information reportedDental curriculum YesReference No0.96(0.57--1.62)Internet YesReference No0.86(0.52--1.43)**Non-oral health colleague (e.g., medical doctor, nurse practitioner)** YesReference No0.64(0.35--1.18)**Family/friend** YesReference No1.05(0.59--1.87)Professional journal/publication (e.g., oral health journal) YesReference No0.53(0.26--1.10)  HPV vaccine knowledgeHPV vaccine knowledge Below medianReference Above median1.03(0.97--1.09)HPV can cause oropharyngeal cancer TrueReference False/Don\'t know/Missing0.89(0.33--2.35)HPV vaccines can protect men and women against HPV related oropharyngeal cancer TrueReference False/Don\'t know/Missing1.13(0.65--1.97)  Barriers to discussing HPVI do not have enough information about the HPV vaccines Did not agreeReferenceReference Agree0.54(0.33--0.90)0.69(0.39--1.25)I am concerned with the safety of the HPV vaccines Did not agreeReference Agree0.54(0.26--1.10)Liability reasons Did not agreeReference Agree0.67(0.41--1.09)I do not believe it is my role as an oral health professional to recommend the HPV vaccines to my patients Did not agreeReferenceReference Agree0.46(0.27--0.79)1.04(0.51--2.11)There are no established professional policies/guidelines pertaining to recommendation of the HPV vaccines Did not agreeReference Agree0.93(0.58--1.50)There is not enough time to discuss this during appointments Did not agreeReferenceReference Agree0.51(0.31--0.85)0.58(0.33--1.02)I am not comfortable discussing sexual history/topics with patients Did not agreeReferenceReference Agree0.45(0.28--0.74)0.66(0.35--1.22)Politics play a role in discussing HPV and the HPV vaccines in the dental office Did not agreeReference Agree1.04(0.64--1.70)Social and cultural norms play a role in discussing HPV and the HPV vaccines in the dental office Did not agreeReference Agree0.80(0.46--1.40)A patient\'s religious ideology plays a role in discussing HPV and the HPV vaccines in the dental office Did not agreeReference Agree1.07(0.65--1.76)  Communication about HPVDo not discuss HPV in the clinic setting and/or have no plans to start Have discussedReferenceReference Have not discussed/No plans to start0.38(0.21--0.70)0.55(0.27--1.13)  Scope of practiceDiscussing the link between HPV and oropharyngeal cancer falls within the scope and role of a dental professional. Did not agreeReference Agreed1.00(0.53--1.89)Recommending HPV vaccination falls within the scope and role of a dental professional. Did not agreeReferenceReference Agreed2.14(1.32--3.46)1.39(0.79--2.44)Administering the HPV vaccines inside the dental office falls within the scope and role of a dental professional. Did not agreeReferenceReference Agreed6.02(2.47--14.71)5.9(2.27--15.3)[^3][^4]

### 3.1.1. Willingness to train {#s0060}

The barriers of 1) not believing that is was the role of the oral health professional to recommend the HPV vaccine to patients, 2) perceiving a lack of time, and 3) discomfort talking to patients about the HPV vaccine, clinical communication practices (not discussing HPV in the clinic setting), and perceptions of scope of practice (recommending the HPV vaccine and administer the HPV vaccine falls within the dental scope of practice) were significantly associated with oral hygiene students\' willingness to train to administer the HPV vaccine in the unadjusted models.

Accounting for the other variables in the model, participants who agreed that recommending HPV vaccination was within the scope and role of a dental professional had almost twice the odds of being willing to train to administer the HPV vaccine compared to those who disagreed (OR = 1.95, 95% CI = 1.14--3.35). Participants who agreed that administering the HPV vaccine in the dental office fell within the scope and role of a dental professional had 3.79 times the odds (95% CI = 1.63--8.81) of being willing to train to administer the HPV vaccine compared to those who disagreed.

### 3.1.2. Willingness to administer {#s0065}

In unadjusted models, the items: 1) number of patients seen per week, 2) I do not have enough information about the HPV vaccines, 3) I do not believe it is my role as an oral health professional to recommend the HPV vaccines to my patients, 4) there is not enough time to discuss this during appointments, 5) I am not comfortable discussing sexual history/topics with patients, 6) have not discussed HPV with patients/no plans to start, 7) recommending HPV vaccination falls within the scope and role of a dental professional, and 8) administering the HPV vaccines inside the dental offices falls within the scope and role of a dental professional were significantly associated with being willing to administer the HPV vaccine once trained. These variables were included in the final adjusted multivariable models.

Accounting for these variables, participants who saw 21 or more patients a week had 4.47 times the odds (95% CI = 1.14--17.58) of being willing to administer the HPV vaccine compared to those who saw 0--10 patients a week. Participants who perceived that administering the HPV vaccines was within the scope and role of a dental professional had almost 6 times the odds (95% CI = 2.27--15.3) to be willing to administer the HPV vaccine compared to those who disagreed in the adjusted model.

4. Discussion {#s0070}
=============

While knowledge about HPV and its relationship with OPC has been the focus of studies among dental professionals and students ([@bb0115]) our findings suggest that knowledge alone may not be the deciding factor in dental professionals\' willingness to train or administer the HPV vaccine. The other perceived barriers for dental practices being involved in HPV vaccination, such as being able to accommodate increased time in patient-provider communication, and increasing providers\' comfort level in talking about STIs in relation to OPC exist. While improving dental professional training with regards to HPV-OPC, and the development of clinical practices to accommodate the HPV discussions may be helpful efforts to engage providers in HPV vaccination, system-level barriers may pose a greater obstacle to dental professionals in engaging in HPV cancer prevention.

We found that the main barrier among dental students was role conflict -- in particular, students did not perceive that it was the role and scope of an oral health professional to recommend or administer the HPV vaccine, which affected the likelihood of participants willing to train, and administer the HPV vaccine. Currently, administering the HPV vaccine is not in standard practice in dental settings; as such, there is a lack of similar studies examining these outcomes. However, studies that examined willingness to educate and recommend the HPV vaccine have been conducted in the United States. A recent mixed-method focus group study by Kline et al. found that oral health professionals may be open to engage in HPV cancer prevention related activities that are synergistic with their existing roles; for example, the study reported dental hygienists perceived comfort in primary prevention efforts with the HPV vaccine as it was in line with their perceived roles of being specialists in preventive care ([@bb0085]). As administering the HPV vaccine is not in current practice, to improve the willingness of dental professionals for vaccine-related activities would require a strong statement of support by professional organizations for HPV vaccine administration in the dental setting. This finding is in alignment with other studies that emphasize oral health professionals\' need for strong support from professional dental associations in encouraging and facilitating dental professionals in HPV patient education ([@bb0140]; [@bb0045]).

We found that participants who had higher amounts of clinical exposure were more willing to administer the HPV vaccine in the dental setting. While potential reasons are not clear, it could be possible that participants who saw greater number of patients are also seeing greater numbers of pediatric patients in the vaccine eligible age range. Future research should examine the differences in willingness to administer the HPV vaccine among subspecialties of dentistry and explore the feasibility of engaging pediatric dentists in HPV cancer prevention. Another aspect of HPV vaccine administration in the dental setting that was not explored within the scope of this study was parental acceptability of children receiving the HPV vaccine at their dentists. A national survey of parents found that parents had lower confidence in their children receiving the HPV vaccine from their dentists but expressed greater acceptability of receiving HPV vaccine education in the dental setting ([@bb0090]). Future research should explore the willingness of oral health professionals and students to engage in other roles related to HPV vaccination, such as education, recommending, and collaborating with primary care providers to improve HPV vaccination rates within communities, particularly those that have high volumes of patients.

Oral health students represent the next generation of dental professionals. Including HPV vaccination as the scope and role of the dental professional will require a large shift in the culture of dentistry to include primary prevention of HPV-OPC. Creating strategies to emphasize oral health professionals\' role in cancer prevention and addressing the barriers to training and administration of the HPV vaccine will be important to reduce the prevalence of HPV-OPCs in the population. Academic institutions not only have a large responsibility to prepare the dental workforce to address the challenges of HPV-OPC in the population, but to strongly advocate and support the role of the dental professional in preventing HPV-OPCs as well. However, steps toward this role change may require restructuring of current dental programs. A study of associate and graduate pediatric dentistry program directors found that while 77% of the participants supported dental professionals discussing the HPV vaccine with their patients, only a quarter of programs had discussed HPV and the HPV vaccine in their curriculum ([@bb0075]).

4.1. Limitations {#s0075}
----------------

The purposive sampling approach was a limitation of this study, which was addressed by stratifying analyses by school. Furthermore, the larger confidence levels in some of the findings may limit generalizations for some results. Additionally, the analyses were conducted with only participants who provided complete data. Thus, there is a potential for the results to be biased because of missing data. Nevertheless, the inclusion of multiple sites across the US and the adjustment for confounders in the analyses are a strength of this study.

5. Conclusions {#s0080}
==============

This is the first multi-state study to examine the willingness of oral health students to train to administer and administer the HPV vaccine once they are trained, in the dental setting. Our findings indicate that overall, a majority of oral health students may be open to receiving training to administer the HPV vaccine and to administer the HPV vaccine once they are trained. A recent position statement from the Society of Behavioral Medicine calls for an increased and coordinated effort to develop and improve clinical practices and HPV vaccination to address the rising trend of OPCs ([@bb0105]). It is imperative that dental education emphasize the importance of HPV vaccination within the curriculum to prepare new generations of oral health professionals as part of these efforts.
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[^1]: Significance was set at the *p* \< 0.05 level.

[^2]: Significant variables identified in the unadjusted models were entered into the multivariable models.

[^3]: Significance was set at the *p* \< 0.05 level.

[^4]: Significant variables identified in the unadjusted models were entered into the multivariable models.
